SGLT-2 inhibitors
https://themeditary.com/dosage-information/steglatro-dosage-4084.html

Steglatro Dosage

Drug Detail:Steglatro (Ertugliflozin [ er-too-gli-floe-zin ])

Generic Name: ERTUGLIFLOZIN PIDOLATE 5mg

Dosage Form: tablet, film coated

Drug Class: SGLT-2 inhibitors

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Prior to Initiation of STEGLATRO

  • Assess renal function prior to initiation of STEGLATRO and as clinically indicated [see Warnings and Precautions (5.3)].
  • In patients with volume depletion, correct this condition before initiating STEGLATRO [see Warnings and Precautions (5.3), Use in Specific Populations (8.5, 8.6)].

Recommended Dosage

  • The recommended starting dose of STEGLATRO is 5 mg once daily, taken in the morning, with or without food.
  • For additional glycemic control, the dose may be increased to 15 mg once daily in patients tolerating STEGLATRO.
  • Use of STEGLATRO is not recommended in patients with an eGFR less than 45 mL/min/1.73 m2.
  • STEGLATRO is contraindicated in patients on dialysis.
Share this Article
Latest News
Related Drugs